Muvalaplin for atherosclerosis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 2 Sep 2025: Trial started, NCT07157774
  2. 5 Sep 2025: Trial registered, NCT07157774

The trials

NCT07157774: Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

State
Under way
Phase
Phase 3
People
10,450 planned
Started
2 Sep 2025
Primary completion
Mar 2031
Arms
Muvalaplin
Results
None posted
  1. 2 Sep 2025: Trial started
  2. 5 Sep 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.